Literature DB >> 31890691

Sarcopenia disease in Iran: an overview.

Gita Shafiee1, Ramin Heshmat1, Afshin Ostovar2, Iraj Nabipour3, Bagher Larijani4.   

Abstract

BACKGROUND: Sarcopenia is a geriatric disease with adverse clinical outcomes, high rate of mortality and a major challenge to healthy elderly. This study aimed to undertake a survey to identify gaps and highlight strengths in sarcopenia research in order to progress research in this area for the next years in Iran.
METHODS: This study included all studies published from the beginning until the first of 2019 in national and international journals by Iranian authors conducted in the field of sarcopenia. The databases including MEDLINE (via PubMed), Web of Science and SCOPUS were used as the sources of information. All relevant available academic studies, including review articles, original articles, case reports, conference abstracts, and letters were included in the analysis.
FINDINGS: A total of 48 articles obtained and then categorized into six groups. These groups were; about Pathophysiology, Epidemiology of sarcopenia, Screening of sarcopenia, Nutrition, Physical activity and Association of Sarcopenia and Other Diseases that briefly findings of each study had been described. These findings showed that the prevalence of sarcopenia was 16.5% to 32.5%, using different definitions. A study developed and validated a screening model for identifying people with sarcopenia. Lifestyle changes such as diet can be appropriate strategies for the prevention of sarcopenia and also, physical activity is considered to be one of the few effective strategies to improve sarcopenia and prevent its outcomes, especially if in combination with appropriate nutritional supplementation. Sarcopenia is associated with adverse outcomes and other serious areas such as metabolic disorders, cancers, cardiovascular diseases, nephrology, gastroenterology, psychiatry, other geriatric diseases (such as osteoporosis, etc) and death. Some studies about these areas have been done in Iran.
CONCLUSIONS: By this study, we found that studies on sarcopenia, the gaps of sarcopenia research in Iran, and highlighted the research priorities for future works. The outcome of the present research is to ultimately improve the health, quality of life and well-being of sarcopenic people. © Springer Nature Switzerland AG 2019.

Entities:  

Keywords:  Iran; Research; Sarcopenia

Year:  2019        PMID: 31890691      PMCID: PMC6915182          DOI: 10.1007/s40200-019-00452-9

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  32 in total

1.  Relationship between major dietary patterns and sarcopenia among menopausal women.

Authors:  Reza Mohseni; Sima Aliakbar; Afsoun Abdollahi; Mir Saeed Yekaninejad; Zhila Maghbooli; Khadijeh Mirzaei
Journal:  Aging Clin Exp Res       Date:  2017-02-21       Impact factor: 3.636

2.  Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia.

Authors:  Liang-Kung Chen; Li-Kuo Liu; Jean Woo; Prasert Assantachai; Tung-Wai Auyeung; Kamaruzzaman Shahrul Bahyah; Ming-Yueh Chou; Liang-Yu Chen; Pi-Shan Hsu; Orapitchaya Krairit; Jenny S W Lee; Wei-Ju Lee; Yunhwan Lee; Chih-Kuang Liang; Panita Limpawattana; Chu-Sheng Lin; Li-Ning Peng; Shosuke Satake; Takao Suzuki; Chang Won Won; Chih-Hsing Wu; Si-Nan Wu; Teimei Zhang; Ping Zeng; Masahiro Akishita; Hidenori Arai
Journal:  J Am Med Dir Assoc       Date:  2014-02       Impact factor: 4.669

3.  Muscle wasting in young patients with dilated cardiomyopathy.

Authors:  Marjan Hajahmadi; Sara Shemshadi; Ehsan Khalilipur; Ahmad Amin; Sepideh Taghavi; Majid Maleki; Hadi Malek; Nasim Naderi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-03-01       Impact factor: 12.910

4.  Bushehr Elderly Health (BEH) programme: study protocol and design of musculoskeletal system and cognitive function (stage II).

Authors:  Gita Shafiee; Afshin Ostovar; Ramin Heshmat; Hossein Darabi; Farshad Sharifi; Alireza Raeisi; Neda Mehrdad; Zhaleh Shadman; Faride Razi; Mohammad Reza Amini; Seyed Masoud Arzaghi; Hamidreza Aghaei Meybodi; Akbar Soltani; Iraj Nabipour; Bagher Larijani
Journal:  BMJ Open       Date:  2017-08-04       Impact factor: 2.692

Review 5.  Curcumin: An effective adjunct in patients with statin-associated muscle symptoms?

Authors:  Amirhossein Sahebkar; Nikou Saboni; Matteo Pirro; Maciej Banach
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-09-22       Impact factor: 12.910

6.  Introducing the 'Drucebo' effect in statin therapy: a systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions.

Authors:  Peter E Penson; G B John Mancini; Peter P Toth; Seth S Martin; Gerald F Watts; Amirhossein Sahebkar; Dimitri P Mikhailidis; Maciej Banach
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-10-11       Impact factor: 12.910

7.  Sarcopenia and its determinants among Iranian elderly (SARIR): study protocol.

Authors:  Rezvan Hashemi; Ramin Heshmat; Ahmadreza Dorosty Motlagh; Moloud Payab; Ahmad Esmaillzadeh; Fereshteh Baigy; Parvin Pasalar; Fereydoun Siassi
Journal:  J Diabetes Metab Disord       Date:  2012-11-21

8.  Body composition in adults with newly diagnosed type 2 diabetes: effects of metformin.

Authors:  Rokhsareh Aghili; Mojtaba Malek; Ameneh Ebrahim Valojerdi; Zahra Banazadeh; Laily Najafi; Mohammad Ebrahim Khamseh
Journal:  J Diabetes Metab Disord       Date:  2014-08-21

9.  Identification of candidate genes and proteins in aging skeletal muscle (sarcopenia) using gene expression and structural analysis.

Authors:  Gita Shafiee; Yazdan Asgari; Akbar Soltani; Bagher Larijani; Ramin Heshmat
Journal:  PeerJ       Date:  2018-09-05       Impact factor: 2.984

10.  The Effect of Fun Physical Activities on Sarcopenia Progression among Elderly Residents in Nursing Homes: a Randomized Controlled Trial.

Authors:  Zohre Najafi; Hadi Kooshyar; Reza Mazloom; Amin Azhari
Journal:  J Caring Sci       Date:  2018-09-01
View more
  6 in total

1.  The association between muscle indicators and bone mass density and related risk factors in the diabetic elderly population: Bushehr Elderly Health (BEH) Program.

Authors:  Marzieh Nikfarjam; Ramin Heshmat; Safoora Gharibzadeh; Afshin Ostovar; Vahid Maleki; Jalal Moludi; Iraj Nabipour; Gita Shafiee; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2021-08-25

2.  Comparison of EWGSOP-1and EWGSOP-2 diagnostic criteria on prevalence of and risk factors for sarcopenia among Iranian older people: the Bushehr Elderly Health (BEH) program.

Authors:  Gita Shafiee; Ramin Heshmat; Afshin Ostovar; Fatemeh Khatami; Noushin Fahimfar; Seyed Masoud Arzaghi; Safoora Gharibzadeh; Sara Hanaei; Iraj Nabipour; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2020-05-29

3.  Patterns of Nutrient Intake in Relation to Sarcopenia and Its Components.

Authors:  Amir Bagheri; Rezvan Hashemi; Ramin Heshmat; Ahmadreza Dorosty Motlagh; Ahmad Esmaillzadeh
Journal:  Front Nutr       Date:  2021-04-27

4.  Association between biomarkers of bone health and osteosarcopenia among Iranian older people: The Bushehr Elderly Health (BEH) program.

Authors:  Maryam Fathi; Ramin Heshmat; Mehdi Ebrahimi; Ahmad Salimzadeh; Afshin Ostovar; Ali Fathi; Farideh Razi; Iraj Nabipour; Maryam Moghaddassi; Gita Shafiee
Journal:  BMC Geriatr       Date:  2021-11-19       Impact factor: 3.921

5.  The Relationship Between Food-Based Pro-inflammatory Diet and Sarcopenia: Findings From a Cross-Sectional Study in Iranian Elderly People.

Authors:  Amir Bagheri; Rezvan Hashemi; Sanaz Soltani; Ramin Heshmat; Ahmadreza Dorosty Motlagh; Bagher Larijani; Ahmad Esmaillzadeh
Journal:  Front Med (Lausanne)       Date:  2021-05-10

6.  Association between Food Insecurity and Sarcopenia among Adults Aged ≥65 Years in Low- and Middle-Income Countries.

Authors:  Lee Smith; Louis Jacob; Yvonne Barnett; Laurie T Butler; Jae Il Shin; Guillermo F López-Sánchez; Pinar Soysal; Nicola Veronese; Josep Maria Haro; Ai Koyanagi
Journal:  Nutrients       Date:  2021-05-31       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.